NCT00060086View on ClinicalTrials.gov

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

May 25, 2021

Study Completion Date

May 25, 2021

Conditions
Prostate Cancer
Interventions
DIETARY_SUPPLEMENT

pomegranate juice

Subjects receive oral pomegranate juice once daily. Treatment continues for 18 months in the absence of disease progression or unacceptable toxicity.

Trial Locations (1)

90095-1738

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

All Listed Sponsors
collaborator

POM Wonderful LLC

INDUSTRY

lead

Jonsson Comprehensive Cancer Center

OTHER

NCT00060086 - Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter